Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Schizophrenia Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 First-Generation Antipsychotic Drugs
1.2.3 Second-Generation Antipsychotic Drugs
1.2.4 Third-Generation Antipsychotic Drugs
1.3 Market by Application
1.3.1 Global Schizophrenia Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Schizophrenia Therapeutics Market Perspective (2018-2033)
2.2 Schizophrenia Therapeutics Growth Trends by Region
2.2.1 Global Schizophrenia Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Schizophrenia Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Schizophrenia Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Schizophrenia Therapeutics Market Dynamics
2.3.1 Schizophrenia Therapeutics Industry Trends
2.3.2 Schizophrenia Therapeutics Market Drivers
2.3.3 Schizophrenia Therapeutics Market Challenges
2.3.4 Schizophrenia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Schizophrenia Therapeutics Players by Revenue
3.1.1 Global Top Schizophrenia Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Schizophrenia Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Schizophrenia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Schizophrenia Therapeutics Revenue
3.4 Global Schizophrenia Therapeutics Market Concentration Ratio
3.4.1 Global Schizophrenia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Schizophrenia Therapeutics Revenue in 2022
3.5 Schizophrenia Therapeutics Key Players Head office and Area Served
3.6 Key Players Schizophrenia Therapeutics Product Solution and Service
3.7 Date of Enter into Schizophrenia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Schizophrenia Therapeutics Breakdown Data by Type
4.1 Global Schizophrenia Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Schizophrenia Therapeutics Forecasted Market Size by Type (2024-2033)
5 Schizophrenia Therapeutics Breakdown Data by Application
5.1 Global Schizophrenia Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Schizophrenia Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Schizophrenia Therapeutics Market Size (2018-2033)
6.2 North America Schizophrenia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Schizophrenia Therapeutics Market Size by Country (2018-2023)
6.4 North America Schizophrenia Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Schizophrenia Therapeutics Market Size (2018-2033)
7.2 Europe Schizophrenia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Schizophrenia Therapeutics Market Size by Country (2018-2023)
7.4 Europe Schizophrenia Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Schizophrenia Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Schizophrenia Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Schizophrenia Therapeutics Market Size (2018-2033)
9.2 Latin America Schizophrenia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Schizophrenia Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Schizophrenia Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Schizophrenia Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Schizophrenia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Schizophrenia Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Schizophrenia Therapeutics Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Schizophrenia Therapeutics Introduction
11.2.4 Eli Lilly Revenue in Schizophrenia Therapeutics Business (2018-2023)
11.2.5 Eli Lilly Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Schizophrenia Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Schizophrenia Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Alkermes
11.5.1 Alkermes Company Detail
11.5.2 Alkermes Business Overview
11.5.3 Alkermes Schizophrenia Therapeutics Introduction
11.5.4 Alkermes Revenue in Schizophrenia Therapeutics Business (2018-2023)
11.5.5 Alkermes Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Schizophrenia Therapeutics Introduction
11.6.4 AbbVie Revenue in Schizophrenia Therapeutics Business (2018-2023)
11.6.5 AbbVie Recent Development
11.7 Amgen
11.7.1 Amgen Company Detail
11.7.2 Amgen Business Overview
11.7.3 Amgen Schizophrenia Therapeutics Introduction
11.7.4 Amgen Revenue in Schizophrenia Therapeutics Business (2018-2023)
11.7.5 Amgen Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Schizophrenia Therapeutics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2018-2023)
11.8.5 Bristol-Myers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Schizophrenia Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of First-Generation Antipsychotic Drugs
Table 3. Key Players of Second-Generation Antipsychotic Drugs
Table 4. Key Players of Third-Generation Antipsychotic Drugs
Table 5. Global Schizophrenia Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Schizophrenia Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Schizophrenia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Schizophrenia Therapeutics Market Share by Region (2018-2023)
Table 9. Global Schizophrenia Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Schizophrenia Therapeutics Market Share by Region (2024-2033)
Table 11. Schizophrenia Therapeutics Market Trends
Table 12. Schizophrenia Therapeutics Market Drivers
Table 13. Schizophrenia Therapeutics Market Challenges
Table 14. Schizophrenia Therapeutics Market Restraints
Table 15. Global Schizophrenia Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Schizophrenia Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Schizophrenia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Schizophrenia Therapeutics as of 2022)
Table 18. Ranking of Global Top Schizophrenia Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Schizophrenia Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Schizophrenia Therapeutics Product Solution and Service
Table 22. Date of Enter into Schizophrenia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Schizophrenia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Schizophrenia Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Schizophrenia Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Schizophrenia Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Schizophrenia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Schizophrenia Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Schizophrenia Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Schizophrenia Therapeutics Revenue Market Share by Application (2024-2033)
Table 32. North America Schizophrenia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Schizophrenia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Schizophrenia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Schizophrenia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Schizophrenia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Schizophrenia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Schizophrenia Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Schizophrenia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Schizophrenia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Schizophrenia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Schizophrenia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. AstraZeneca Company Detail
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Schizophrenia Therapeutics Product
Table 50. AstraZeneca Revenue in Schizophrenia Therapeutics Business (2018-2023) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Schizophrenia Therapeutics Product
Table 55. Eli Lilly Revenue in Schizophrenia Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Schizophrenia Therapeutics Product
Table 60. GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2018-2023) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Johnson & Johnson Company Detail
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Schizophrenia Therapeutics Product
Table 65. Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. Alkermes Company Detail
Table 68. Alkermes Business Overview
Table 69. Alkermes Schizophrenia Therapeutics Product
Table 70. Alkermes Revenue in Schizophrenia Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Alkermes Recent Development
Table 72. AbbVie Company Detail
Table 73. AbbVie Business Overview
Table 74. AbbVie Schizophrenia Therapeutics Product
Table 75. AbbVie Revenue in Schizophrenia Therapeutics Business (2018-2023) & (US$ Million)
Table 76. AbbVie Recent Development
Table 77. Amgen Company Detail
Table 78. Amgen Business Overview
Table 79. Amgen Schizophrenia Therapeutics Product
Table 80. Amgen Revenue in Schizophrenia Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Amgen Recent Development
Table 82. Bristol-Myers Squibb Company Detail
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Schizophrenia Therapeutics Product
Table 85. Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Schizophrenia Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Schizophrenia Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. First-Generation Antipsychotic Drugs Features
Figure 4. Second-Generation Antipsychotic Drugs Features
Figure 5. Third-Generation Antipsychotic Drugs Features
Figure 6. Global Schizophrenia Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Schizophrenia Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Schizophrenia Therapeutics Report Years Considered
Figure 12. Global Schizophrenia Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Schizophrenia Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Schizophrenia Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Schizophrenia Therapeutics Market Share by Players in 2022
Figure 16. Global Top Schizophrenia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Schizophrenia Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Schizophrenia Therapeutics Revenue in 2022
Figure 18. North America Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Schizophrenia Therapeutics Market Share by Country (2018-2033)
Figure 20. United States Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Schizophrenia Therapeutics Market Share by Country (2018-2033)
Figure 24. Germany Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Schizophrenia Therapeutics Market Share by Region (2018-2033)
Figure 32. China Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Schizophrenia Therapeutics Market Share by Country (2018-2033)
Figure 40. Mexico Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Schizophrenia Therapeutics Market Share by Country (2018-2033)
Figure 44. Turkey Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Schizophrenia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Schizophrenia Therapeutics Business (2018-2023)
Figure 47. Eli Lilly Revenue Growth Rate in Schizophrenia Therapeutics Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Schizophrenia Therapeutics Business (2018-2023)
Figure 49. Johnson & Johnson Revenue Growth Rate in Schizophrenia Therapeutics Business (2018-2023)
Figure 50. Alkermes Revenue Growth Rate in Schizophrenia Therapeutics Business (2018-2023)
Figure 51. AbbVie Revenue Growth Rate in Schizophrenia Therapeutics Business (2018-2023)
Figure 52. Amgen Revenue Growth Rate in Schizophrenia Therapeutics Business (2018-2023)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Therapeutics Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed